1.
Lee H, Duggan P, Neri EP, Tay J, Zepeda V. Bortezomib maintenance for the treatment of Monoclonal Gammopathy of Renal Significance. MJHID [Internet]. 1Jan.2019 [cited 19Feb.2019];11(1). Available from: https://www.mjhid.org/index.php/mjhid/article/view/2019.007